Chang David J. 4
4 · Cabaletta Bio, Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Chang David J.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-01+130,000→ 130,000 totalExercise: $23.97Exp: 2034-02-28→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on March 1, 2025, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.